Radiology Doctors in Derry, NH Accepting Medicare

6 Radiology doctors found. Showing 1 - 6

Dr. Carl Richard Makarewicz, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 15 Mill Rd, Derry, NH 03038 Phone: 509-528-5779

Dr. Matthew Louise Levine, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Derry, NH 03038 Phone: 603-883-4636    Fax: 603-883-6854

Dr. Philip Wayne Grant, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd Ste 100ll, Derry, NH 03038 Phone: 603-883-4636    Fax: 603-883-6854

Dr. Benjamin Bentley Faitelson, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd Ste 100ll, Derry, NH 03038 Phone: 603-883-4636    Fax: 603-883-6854

Banu Oner, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3 Kendall Pond Rd, Derry, NH 03038 Phone: 952-595-1100    Fax: 612-294-4903

William M. Sherman Jr., M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd Ste 100ll, Derry, NH 03038 Phone: 603-883-4636    Fax: 603-883-6854

News Archive

Research shows key role of diffusion dynamics in stem cell differentiation and tissue development

Gradients of molecular signaling factors play an essential role in numerous events in embryonic development, from patterning limb and organ formation to the intricate shaping of the brain and neuroanatomical architecture.

H2S plays a major role in protecting bacteria from effects of different antibiotics

Although scientists have known for centuries that many bacteria produce hydrogen sulfide (H2S) it was thought to be simply a toxic by-product of cellular activity. Now, researchers at NYU School of Medicine have discovered H2S in fact plays a major role in protecting bacteria from the effects of numerous different antibiotics.

FDA announces availability of $2 million for rare disease research

The U.S. Food and Drug Administration today announced the availability of $2 million in research grants to fund natural history studies in rare diseases. The aim is to collect data on how specific rare diseases progress in individuals over time so that knowledge can inform and support product development and approval. This will be the first time the FDA will provide funding through its Orphan Products Grants to conduct these types of studies for rare diseases.

Researchers aim to develop sustained and controllable insulin release system for treatment of diabetes

The prevalence of diabetes has grown around the world over the past three decades. In 2016, the World Health Organization estimated that 422 million people had the disease as the rate of obesity also increased.

One-third of NIH-funded trials remain unpublished 51 months after completion

In a study that investigates the challenges of disseminating clinical research findings in peer-reviewed biomedical journals, Yale School of Medicine researchers have found that fewer than half of a sample of trials primarily or partially funded by the National Institutes of Health (NIH) were published within 30 months of completing the clinical trial.

Read more Medical News

› Verified 1 days ago